University of Cambridge > > SciSoc – Cambridge University Scientific Society > Drug discovery: how Academia can Contribute

Drug discovery: how Academia can Contribute

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact als60.

Bringing together physics, chemistry and some biology, Sir Tom Blundell will be describing how his initiatives in drug discovery have moved to the Science Park in the early 2000s, but are now coming back to academia in order to work on new medicine for rare cancers and the diseases of third world poverty.

Sir Prof Blundell graduated from Brasenose College Oxford, and has held several distinguished research positions at Oxford University, Birkbeck College, and the Imperial Cancer Research Fund Unit. He was Chief Execuitive of BBSRC from 1994-1996. Sir Prof Blundell has founded Astex, a highly successful company specialising in using computational techniques and X-ray crystallography to identify novel cancer drugs.

All welcome; free for Scisoc members, £1 otherwise

This talk is part of the SciSoc – Cambridge University Scientific Society series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity